In eyes with neovascular age-related macular degeneration (nAMD) treated with antivascular endothelial growth factor injections, researchers assessed treatment outcome at 12 months in relation to pro re nata (PRN)- or treat-and-extend (TE)-regimen, in one clinical setting in Sweden. Overall 443 eyes including 223 PRN- and 220 TE-treated eyes were included in this study. Findings revealed better visual outcome at 12 months in eyes treated according to TE. In clinical routine care of nAMD, the superiority of treatment according to proactive TE-regimen, compared with treatment according to PRN-regimen, is suggested.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *